Morning Break: Bugs on Scopes, Still; Vax Ebola Works; Kratom deaths

Please note that some links may require subscriptions.

Corruption is a problem on duodenoscopes, said the FDA on Friday, indicating that the most recent sampling data showed that "high concern organisms" at higher rates after reprocessing (up to 5.4%) than were previously reported.

Another situation of apparatus reprocessing has gone badly: the agency said that Bivona brand tracheostomy tubes, especially those that are medium-sized for children, "temporary shortage" is now due to a February closure in a sterilization facility.

From, large, problem of new measles: positive positive test results. (Detroit Free Press)

The Ebola case in the Democratic Republic of Congo is not yet an international concern, a WHO committee has decided, as the outbreak is not dispersed to neighboring countries and is still confined to areas where they have already been seen.

And the WHO said that pre-data shows that the rVSV-ZEBOV-GP Ebola vaccine is extremely effective in reducing infections.

Did Stanford's professor help the scientist behind the children who were edited by CRISPR? (New York Times)

Kratom linked to 91 deaths in 27 states. (ABC News)

Data published – and not published – on the test of the Beckman Coulter Prostate Health Index grows controversy. (STAT)

More concern about Latin immigrant medical treatment and mental health in US detention facilities. (Kaiser Health News)

Billions of dollars are now riding the success of gene therapies. (Endpoints News)

Vox polluting drinking water is acceptable under circumstances where the alternative would be significantly worse.

An automated external defibrillator wins – Stryker's Lifepak CR2 – pre-market approval from the FDA. (mass)

Morning Break is a daily guide to what is new and interesting on the Web for healthcare professionals, powered by MedPage Today community. You got top? Send it to us:

1969-12-31T19: 00: 00-0500

last updated


Leave a comment

Send a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.